Versions Compared

Old Version 5

changes.mady.by.user Alex

Saved on

compared with

New Version Current

changes.mady.by.user Alex

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Author

  • The Perth Group

Publisher

  • -

Category

  • Controversy

Topic

  • AIDS Paradox

  • Pearth Group

  • Tuberculosis

  • HIV Antibody

  • T4 Cells

Article Type

  • Editorial article

Publish Year

  • 2011

Meta Description

  • Perth Group's views on HIV/AIDS are discussed, questioning the mainstream understanding. They face criticism but maintain their stance, citing published works.

Summary

  • This is a statement from the Perth Group regarding their views on "HIV/AIDS." They argue that the HIV theory of AIDS is flawed and provide evidence to support their claims. They suggest that experiments should be conducted to prove their theory wrong. The group also emphasizes that their public health policies align with those of HIV experts. They advocate for safe sexual practices, clean needles, and testing all blood and blood products. They mention that antiretroviral drugs do not prove the HIV theory of AIDS. The statement also discusses the issues with HIV antibody testing and its relationship to AIDS. Overall, the Perth Group challenges the mainstream understanding of HIV/AIDS and presents their alternative perspective.

Meta Tag

  • Perth Group

  • HIV/AIDS

  • Virological response

  • Clinical progression

  • Tuberculosis

  • Sub-Saharan Africa

  • CD4 cell counts

  • AIDS-defining event

  • Cellular oxidation theory

  • Pseudo-scientists

  • Antibody tests

  • Retrovirus "HIV"

Featured Image

Featured Image Alt Tag

  • Keyword of the image

Original Publication
The Perth Group

View file
namePG_Statement.pdf

...

1. Our public health policies accord with and in fact go beyond those of the HIV experts. Hence it is not possible we are dangerous.

We advocate:

a.  safe  safe sexual practices apply to passive anal intercourse with both HIV positive and HIV negative partners.

b.  clean  clean needles but the best option is no drugs and hence no need for needles.

c.   testing  testing all blood and blood products.

2. There are two old fashioned ways to prove we are pseudo-scientists:

a.  With  With great difficulty we have managed to publish papers in scientific journals. Such individuals, whoever they may be, should write to the editors of such journals submitting their evidence.

b.  Any  Any scientist who understands the cellular oxidation theory of AIDS will have no trouble designing experiments to prove our theory wrong. Montagnier seems to understand because he has long been an apologist12 for our theory, at least in Africa.28 The expertise required to perform such experiments falls well within the abilities of the HIV experts with access to a reasonably sized laboratory. In terms of AIDS funding the cost of such experiments would be trivial.

REFERENCES

Expand
titleClick here to expand..

  1. Papadopulos-Elepopulos E, Turner VF, Papadimitriou JM, Bialy H. AIDS in Africa: Distinguishing fact and fiction. World J Microbiol Biotechnol. 1995; 11: 135-43. http://www.theperthgroup.com/SCIPAPERS/africafactandfiction.html

  2. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship. Genetica. 1995; 95: 25-50. http://www.theperthgroup.com/SCIPAPERS/ephemophilia.html

  3. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. Kaposi's sarcoma and HIV. Med Hypotheses. 1992; 39: 22-9.
    http://www.theperthgroup.com/SCIPAPERS/ks.html

  4. Rejected Letter to Lancet.
    http://theperthgroup.com/REJECTED/LancetTBF.doc

  5. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Bialy H. The Haemophilia Connection. Continuum. 1995; 3(4): 17-9.
    http://www.theperthgroup.com/CONTINUUM/HaemophiliaConn.pdf

  6. Response to Jeanne Bergman "HON lies about T cells". http://theperthgroup.com/HON/PGBergmanHONNov242009.html

  7. Response to Jeanne Bergman "Real Answers to Fake Questions". hthttp://theperthgroup.com/HON/PGHONFakeQuestionsDec042009.html

  8. Commentary on the House of Numbers extended interviews in regard to the existence of HIV. www.theperthgroup.com/OTHER/ENVCommentary.pdf

  9. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Hedland-Thomas B, Causer D, Page B. A critical analysis of the HIV-T4-cell-AIDS hypothesis. Genetica. 1995; 95: 5-24. http://www.theperthgroup.com/SCIPAPERS/ept4cells.html

  10. Papadopulos-Eleopulos E. Reappraisal of AIDS: Is the oxidation caused by the risk factors the primary cause? Med Hypotheses. 1988; 25: 151-62. http://www.theperthgroup.com/SCIPAPERS/reappraisalofaids.html

  11. Papadopulos-Eleopulos E. Looking back on the oxidative stress theory of AIDS. Continuum. 1998; 5(5): 30-5.
    http://theperthgroup.com/CONTINUUM/lookingback.html

  12. Papadopulos-Eleopulos E, Page BA, Causer D, Turner VF, Papadimitriou JM, Alfonso H. Would Montagnier please clarify whether HIV or oxidation by the risk factors is the primary cause of AIDS? Med Hypotheses. 2006; 67(3): 666-8. http://theperthgroup.com/SCIPAPERS/PGMontOSMH2006.pdf

  13. Papadopulos-Eleopulos E, Turner V, Papadimitriou J, Page B, Causer D. Montagnier, T4 cells (acquired immune deficiency) and our oxidative theory of "HIV"/AIDS. 2008 [cited; Available from: www.theperthgroup.com/Nobel/MontagnierOxidation.pdf

  14. Papadopulos-Eleopulos E, Turner V, Weiss R. Email debate with Professor Robin Weiss on the existence of HIV. 1999. http://www.theperthgroup.com/EMAILCORR/vftweiss.html

  15. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. Oxidative stress, HIV and AIDS. Res Immunol. 1992; 143: 145-8.
    http://www.theperthgroup.com/SCIPAPERS/oxstresshivaids.html

  16. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. Is a positive Western blot proof of HIV infection? Biotechnology. 1993; 11: 696-707. http://www.theperthgroup.com/SCIPAPERS/biotek8.html

  17. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Alfonso H, Page BA, Causer D. A critical analysis of the evidence for the existence of HIV. Rapid Response Online British Medical Journal. 2003. http://bmj.com/cgi/eletters/326/7387/495#31507

  18. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo R. Antibodies Reactive to Human T-Lymphotrophic Retroviruses (HTLV-III) in the Serum of Patients with AIDS. Science. 1984; 224: 506-8.

  19. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985; 253: 221-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2981 369&dopt=Abstract

  20. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Alfonso H, Page BAP, Causer D et al. Mother to Child Transmission of HIV and its Prevention with AZT and Nevirapine. Perth: The Perth Group; 2001.

  21. Testimony of Elizabeth Dax.
    http://www.tig.org.za/Parenzee_prosecution_transcripts/index.htm

  22. Kashala O, Marlink R, Ilunga M, Diese M, Gormus B, Xu K, et al. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross- reactivity and antibodies to lipoarabinomannan. J Infect Dis. 1994; 169: 296-304.

  23. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D, Page BA. HIV antibody tests and viral load--more unanswered questions and a further plea for clarification. Curr Med Res Opinion. 1998; 14: 185-6.
    http://www.theperthgroup.com/SCIPAPERS/furtherplea.html

  24. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Stewart G, Causer D. HIV antibodies: further questions and a plea for clarification. Curr Med Res Opinion. 1997; 13: 627-34.http://www.theperthgroup.com/SCIPAPERS/epcurmedres97.html

  25. McIntyre JA, Wagenknecht DR, Faulk WP. Autoantibodies unmasked by redox reactions. Journal of Autoimmunity. 2005; 24(4): 311-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cit ation&list_uids=15927793

  26. Mastrolorenzo A, Rusconi S, Scozzafava A, Barbaro G, Supuran CT. Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors. Current Medicinal Chemistry. 2007; 14(26): 2734-48.

  27. May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006; 368(9534): 451-8.
    http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cit ation&list_uids=16890831

  28. Montagnier L. Apports de la recherche dans la lutte contra le Sida en Afrique. In: Pietteur M, editor. Le sida en Afrique. Belgique: Collection Resurgence; 2004. p. 179.